Trending Now
Allakos Inc. (NASDAQ: ALLK) Releases Results of The ENIGMA And KRYPTOS...
Allakos Inc. (NASDAQ: ALLK) has released results from ENIGMA 2 study, which is a third phase, 24-week, double-blind, controlled lirentelimab study in patients with...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Publishes Data From its Phase II...
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) announced that data from its Phase II clinical trial of fostamatinib for adult patients with warm antibody autoimmune hemolytic...
MAKE IT MODERN
LATEST REVIEWS
Nexoptic Technology Corp (OTCMKTS:NXOPF) surges on increased volume and Qualcomm news...
Shares of Nexoptic Technology Corp (OTCMKTS:NXOPF) have surged over 155% in the past 6 months. At the time of this publication, NXOPF...
MAKE IT MODERN
PERFORMANCE TRAINING
MediciNova Inc. (NASDAQ:MNOV) Reports Promising Results Of Its Intranasal BC-PIV SARS-CoV-2 Vaccine Candidate
MediciNova Inc. (NASDAQ:MNOV) announced that its intranasal COVID-19 vaccine candidate that is employing the BC-PIV tech, induced systemic serum IgG as well as mucosal...
Dynavax Technologies Corporation (NASDAQ: DVAX) And Clover Biopharmaceuticals Announces Results For Their COVID-19 Vaccine
Dynavax Technologies Corporation (NASDAQ: DVAX) has announced that Clover Biopharmaceuticals has released promising data for its protein-based COVID-19 vaccine SCB-2019 adjuvanted with CpG 1018...
BridgeBio Pharma Inc (NASDAQ: BBIO) Issues an Update to Its Shareholders on the Development...
BridgeBio Pharma Inc (NASDAQ: BBIO) issued its shareholders an update of its positive results from phase 2 of its BBP-418 study. The study investigated...
One Stock Positioned to Win as EV Battery Recycling Becomes the Next Big Thing...
The electric vehicle narrative is about using new technology to strike at the heart of one of the most profound drivers of...
Vaxart Inc (NASDAQ: VXRT) Vaccine Boosts Immune System
Vaxart Inc (NASDAQ: VXRT) is a clinical-stage biotechnology company developing an oral treatment based on its platform. The company recently announced that its vaccine...
MAKE IT MODERN
